Table 7. 12 month unadjusted event rates in VTE patients with active cancer.

Outcome	VKA ( N  = 144)		DOAC ( N  = 264)
	Number of events	Rate (95% CI)	Number of events	Rate (95% CI)
All-cause mortality	33	52.51 (37.33 − 73.86)	39	26.52 (19.37 − 26.29)
Recurrent VTE	11	17.93 (9.93 − 32.38)	5	3.40 (1.42 − 8.18)
Major bleeding	7	11.24 (5.36 − 23.58)	6	4.10 (1.84 − 9.12)
Any bleeding	17	28.05 (17.44 − 45.13)	26	18.59 (12.66 − 27.30)
Myocardial infarction	2	3.18 (0.80 − 12.73)	0	N/A
Stroke/TIA	0	N/A	2	1.36 (0.34 − 5.44)

Abbreviations: TIA, transient ischemic attack; VTE, venous thromboembolism.